Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.52 USD
Change Today -0.015 / -2.80%
Volume 563.6K
MSTX On Other Exchanges
As of 8:04 PM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David A. Ramsay MBA

Independent Director, Chairman of Audit Committee, Member of Nominating & Governance Committee and Member of Compensation Committee, Mast Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 3 different industries.

See Board Relationships


Mr. David A. Ramsay, MBA, has been an Executive Advisor of NexDx, Inc. since January 2012. Mr. Ramsay has been the Chief Financial Officer of Halozyme Therapeutics, Inc. since May 23, 2013 and serves as its Vice President. He served as Vice President of Corporate Development of Halozyme Therapeutics, Inc. since May 15, 2009 and served as its Secretary. He served as the Chief Financial Officer of Halozyme Therapeutics Inc. (formerly Global Yacht Services, Inc.) from March ...

Read Full Background

Corporate Headquarters*

3611 Valley Centre Drive
San Diego, California 92130

United States

Phone: 858-552-0866
Fax: 858-552-0876

Board Members Memberships*

Independent Director, Chairman of Audit Committee, Member of Nominating & Governance Committee and Member of Compensation Committee


University of California Berkeley
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$364,875

Stock Options*

Restricted Stock Awards$371,385
All Other Compensation$8,669
Exercised Options70,058
Exercised Options Value$481,883
Exercisable Options163,978
Exercisable Options Value$453,177
Unexercisable Options133,652
Unexercisable Options Value$207,741
Total Value of Options$1,142,800
Total Number of Options367,688

Total Compensation*

Total Annual Cash Compensation$503,430
Total Short Term Compensation$364,875
Other Long Term Compensation$380,054
Total Calculated Compensation$1,241,979
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MSTX:US $0.52 USD -0.015


J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
Yongfeng Zhang Ph.D.Chief Executive Officer, Chief Science Officer and Director
Amphastar Pharmaceuticals, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MAST THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at